Horizontal gene transfers and cell fusions in microbiology, immunology and oncology (Review)

International Journal of Oncology

Volumn 35, Issue 3, 2009, Pages 441-465

  Sinkovics, Joseph G ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Adaptive immunity; Archaea; Cell chimeras; Cell fusions; Cell hybrids; Chromoviruses; Epithelial to mesenchymal transition; Eukaryotes; Fused dendritic cell vaccines; Fusogenic viruses; Horizontal gene transfers; Innate immunity; Macrophage fusion partners; Natural hybridomas; Oncolytic viruses; Osteoclast fusion; Prokaryotes; Proto spheroplasts; Retroviruses; Syncytins; Viral sarcomagenesis; Viral vectors

Indexed keywords

ALPHA INTERFERON; CANCER VACCINE; CYCLOPHOSPHAMIDE; DENDRITIC CELL VACCINE; INTERLEUKIN 2; LYMPHOID ENHANCER FACTOR 1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN; MELANOMA VACCINE; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; ONCOLYTIC VIRUS; ONCOPROTEIN; OSTEONECTIN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TRANSCRIPTION FACTOR SNAIL; VIRUS VECTOR; WNT PROTEIN;

BREAST CANCER; CANCER IMMUNOTHERAPY; CANCER STEM CELL; CARCINOGENESIS; CD8+ T LYMPHOCYTE; CELL DIVISION; CELL FUSION; CHRONIC LYMPHATIC LEUKEMIA; DENDRITIC CELL; EPSTEIN BARR VIRUS; EWING SARCOMA; HORIZONTAL GENE TRANSFER; HUMAN; HUMAN GENOME; HUMAN HERPESVIRUS 8; HUMAN T CELL LEUKEMIA VIRUS; KAPOSI SARCOMA; LONG TERMINAL REPEAT; LOW DRUG DOSE; LYMPHOMA CELL; MACROPHAGE; MALIGNANT TRANSFORMATION; MASON PFIZER MONKEY VIRUS; MELANOMA; MONOCYTE; MURINE LEUKEMIA VIRUS; NONHUMAN; ONCOLYTIC VIROTHERAPY; OSTEOCLAST; PLASMA CELL; PRIORITY JOURNAL; PROTO ONCOGENE; REED STERNBERG CELL; REGULATORY T LYMPHOCYTE; RETROPOSON; RETROVIRUS; REVIEW; SUPERINFECTION; SUPPRESSOR CELL; TUMOR SUPPRESSOR GENE; VIRUS CELL INTERACTION; VIRUS PARTICLE;

ALLERGY AND IMMUNOLOGY; ANIMALS; CELL FUSION; CELL TRANSFORMATION, NEOPLASTIC; EVOLUTION, MOLECULAR; GENE TRANSFER, HORIZONTAL; HUMANS; MICROBIOLOGY;

EID: 70349132310     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000357     Document Type: Review

References (365)

1. Lederberg J and St Clair J: Protoplasts and L-type growth of Escherichia coli. J Bacteriol 75: 143-160, 1958.
2. Woese CR: The universal ancestor. Proc Natl Acad Sci USA 95: 6854-6859, 1998.
3. Woese CR: On the evolution of cells. Proc Natl Acad Sci USA 99: 8742-8747, 2002.
4. MacLeod D, Charlebois RL, Doolittle F and Bapteste E: Deduction of probable events of lateral gene transfer through comparison of phylogenetic trees by recursive consolidation and rearrangement. BMC Evol Biol 5: 27 (online 1-15), 2005.
5. Simonson AB, Servin JA, Skophammer RG, Herbold CW, Rivera MC and Lake JA: Decoding the genomic tree of life. Proc Natl Acad Sci USA 192 (Suppl. 1): 6606-6613, 2005.
6. Dagan T, Artzy-Randrup Y and Martin W: Modular networks and cumulative impact of lateral transfer in prokaryotic genome evolution. Proc Natl Acad Sci USA 105: 10039-10044, 2008.
7. Wächtershäuser G: From pre-cells to Eukarya - a tale of two lipids. Mol Microbiol 47: 13-22, 2003.
8. Koga Y, Kyuragi T, Nishihara M and Sone N: Did archaeal and bacterial cells arise independently from noncellular precursors? A hypothesis stating that the advent of membrane phospholipids with enantiomeric glycerophosphate backbones caused the separation of the two lines of descent. J Mol Evol 46: 54-63, 1998. Erratum: 47: 631, 1998.
9. Dagan T and Martin W: Ancestral genome sizes specify the minimum rate of lateral gene transfer during prokaryote evolution. Proc Natl Acad Sci USA 104: 870-875, 2007.
10. Hartman H and Fedorov A: The origin of the eukaryotic cell: a genomic investigation. Proc Natl Acad Sci USA 99: 1420-1425, 2002. Erratum 99: 4752, 2002.
11. Lester L, Meade A and Pagel M: The slow road to the eukaryotic genome. Bioessays 28: 57-64, 2006.
12. Lane CE and Archibald JM: The eukaryotic tree of life: endosymbiosis takes its TOL. Trends Ecol Evol 23: 268-275, 2008.
13. Saruhashi S, Hamada K, Miyata D, Horiike T and Shinozawa T: Comprehensive analysis of the origin of eukaryotic genomes. Genes Genet Syst 83: 285-291, 2008.
14. Martin W, Rotte C, Hoffmeister M, Theissen U, Gelius-Dietrich G, Ahr S and Henze K: Early cell evolution, eukaryotes, anoxia, sulfide, oxygen, fungi first (?), and a tree of genomes revisited. Internat Union Biochem Mol Biol (IUBMB) Life 55: 193-204, 2003.
15. Moreira D and Philippe H: Sure facts and open questions about the origin and evolution of photosynthetic plastids. Res Microbiol 152: 771-780, 2001.
16. Keeling PJ: Role of horizontal gene transfer in the evolution of photosynthetic eukaryotes and their plastids. Methods Mol Biol 532: 501-515, 2009.
17. Li S, Nosenko T, Hackett JD and Battacharya D: Phylogenomic analysis identifies red algal genes of endosymbiotic origin in the chromalveolates. Mol Biol Evol 23: 663-667, 2006.
18. Nozaki H: A new scenario of plastid evolution: plastid primary endosymbiosis before the divergence of the 'Plantae,' emended. J Plant Res 118: 247-255, 2005.
19. Zhaxybayeva O, Gogarten JP, Charlebois RL, Doolittle WF and Papke RT: Phylogenetic analyses of cyanobacterial genomes: quantification of horizontal gene transfer events. Genome Res 16: 1099-1108, 2006.
20. Ahmadinejad N, Dagan T and Martin W: Genome history in the symbiotic hybrid Euglena gracilis. Gene 402: 35-39, 2007.
21. Henze K, Badr A, Wettern M, Cerff R and Martin W: A nuclear gene of eubacterial origin in Euglena gracilis reflects endosymbioses during protist evolution. Proc Natl Acad Sci USA 92: 9122-9126, 1995.
22. Tilly K and Georgopoulos C: Evidence that the two Escherichia coli groE morphogenetic gene products interact in vivo. J Bacteriol 149: 1082-1088, 1982.
23. Zauner S, Lockhart P, Stoebe-Maier B, Gilson P, McFadden GI and Maier UG: Differential gene transfers and gene duplications in primary and secondary endosymbioses. BioMed Center (BMC) Evol Biol 6: 38-48, 2006.
24. Sato S, Ikeuchi M and Nakamoto H: Expression and function of a groEL paralog in the thermophilic cyanobacterium Thermosynechococcus elongatus under heat and cold stress. FEBS Lett 582: 3389-3395, 2008.
25. Cavalier-Smith T: Archamoebae: the ancestral eukaryotes? Biosystems 25: 25-38, 1991.
26. Cavalier-Smith T: Zooflagellate phylogeny and classification. Tsitologiia 37: 1010-1029, 1995.
27. Doolittle WF and Bapteste E: Pattern pluralism and the Tree of Life hypothesis. Proc Natl Acad Sci USA 104: 2043-2049, 2007.
28. Beiko RG, Doolittle WF and Charlebois RL: The impact of reticulate evolution on gene phylogeny. Syst Biol 57: 844-856, 2008.
29. Cavalier-Smith T: The phagotropic origin of eukaryotes and phylogenetic classification of Protozoa. Int J Syst Evol Microbiol 52: 297-354, 2002.
30. Margulis L: Archaeal-eubacterial mergers in the origin of Eukarya: phylogenetic classification of life. Proc Natl Acad Sci USA 93: 1071-1076, 1996.
31. Gupta RS and Golding GB: The origin of eukaryotic cells. Trends Biochem Sci 21: 166-171, 1996.
32. López-García P and Moreira D: Metabolic symbiosis at the origin of eukaryotes. Trends Biochem Sci 24: 88-93, 1999.
33. Sinkovics JG: The place of viruses in the 'Tree of Life'. Acta Microbiol Immunol Hungar 48: 115-127, 2001.
34. Blobel G: Intracellular protein topogenesis. Proc Natl Acad Sci USA 77: 1496-1500, 1980.
35. Köhler S, Delwiche CF, Denny PW, Tilney LG, Webster P, Wilson RJ, Palmer JD and Roos DS: A plastid of probable green algal origin in Apicomplexan parasites. Science 275: 1485-1489, 1997.
36. Waller RF, Keeling PJ, Donald RGK, Striepen B, Handman E, Lang-Unnasch N, Cowman AF, Besra GS, Roos DS and McFadden GI: Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum. Proc Natl Acad Sci USA 95: 12352-12357, 1998.
37. Cai X, Fuller AL, McDougald LR and Zhu GP: Apicoblast genome of the coccidian Eimeria tenetia. Gene 321: 39-46, 2003.
38. Monier A, Pagarete A, de Vargas C, Allen MJ, Read B, Claverie JM and Ogata H: Horizontal gene transfer of an entire metabolic pathway between a eukaryotic alga and its DNA virus. Genome Res (In press).
39. Koonin EV, Senkevich TG and Dolja VV: The ancient Virus World and evolution of cells. Biol Direct 1: 29-69, 2006.
40. Cech TR: Crawling out of the RNA world. Cell 136: 599-602, 2009.
41. Hendrix RW, Smith MC, Burns RN, Ford ME and Hatfull GF: Evolutionary relationships among diverse bacteriophages and prophages: all the world's a phage. Proc Natl Acad Sci USA 96L: 2192-2197, 1999.
42. House CH: The tree of life viewed through the contents of genomes. Methods Mol Biol 532: 141-161, 2009.
43. Jalasvuori M and Bamford JK: Structural co-evolution of viruses and cells in the primordial world. Orig Life Evol Biosph 38: 165-181, 2008.
44. La Scola B, Desnues C, Pagnier I, Robert C, Barrassi L, Fournous G, Merrchat M, Suzan-Mintyi M, Forterre P, Koonin E and Raoult D: The virophage as a unique parasite of the giant mimivirus. Nature 455: 100-104, 2008.
45. Moreira D and López-García P: Ten reasons to exclude viruses from the tree of life. Nat Rev Microbiol 7: 306-311, 2009.
46. Moreira D and Brochier-Armanet C: Giant viruses, giant chimeras: the multiple evolutionary histories of mimivirus genes. BMC Evol Biol 8: 12-26, 2008.
47. Sinkovics J: Die Grundlagen der Virusforschung. Verlag der Ungarischen Akademie der Wissenschaften, Budapest, pp1-420, 1956.
48. Sinkovics JG: Viruses in the cyclorama of the living matter (in Hungarian with English summary). Studia Physiologica (Scientia Publisher, Budapest) 9: 1-149, 2001.
49. Sinkovics JG: Cytolytic Immune Lymphocytes in the Armamentarium of the Human Host. Schenk Verlag, Passau, Germany & Campus/Dialog, Budapest, Hungary www.buchverlag-schenk.de pp1-391, 2008.
50. Maniloff J: Mycoplasma viruses. CRC Crit Rev Microbiol 15: 339-389, 1988.
51. Bamford DH, Romantschuk M and Somerharju PJ: Membrane fusion in prokaryotes: bacteriophage phi 6 membrane fuses with the Pseudomonas syringae outer membrane. EMBO J 6: 1467-1473, 1987.
52. Sinkovics J: Pleuropneumonia-ahnliche Eigenheiten in alten E. coli Kulturen. Acta Microbiol Hung 4: 59-75, 1957.
53. Sinkovics J: Occurrence and filterability of protoplast-like elements in aged bacterial cultures. Nature 181: 566-567, 1958.
54. Lindås A-C, Karlsson EA, Lindgren MT, Etterna TJG and Bernander R: A unique cell division machinery in the Archaea. Proc Natl Acad Sci USA 105: 18942-18946, 2008.
55. Cox CJ, Foster PG, Hirt RP, Harris SR and Embley TM: The archaeal origin of eukaryotes. Proc Natl Acad Sci USA 105: 20356-20361, 2008.
56. Andreu JM, Oliva MA and Monastero O: Reversible unfolding of FtsZ cell division proteins from Archaea and Bacteria. J Biol Chem 45: 43262-43270, 2002.
57. Obita T, Saksena S, Ghazi-Tabatabai S, Gill DJ, Perisic O, Emr SD and Williams RL: Structural basis for selective recognition of ESCRT-III by the AAA ATPase Vps4. Nature 449: 735-739, 2007.
58. Huesca S, Schaffner-Barbero C, García W, Yébenes M, Palacios KM, Menéndez M and Andreu JM: The interaction of cell division protein FtsZ with guanine nucleotides. J Biol Chem 282: 37515-37528, 2007.
59. Ghazi-Tabatabai S, Obita T, Pobbati AV, Perisic O, Samson RY, Bell SD and Williams RL: Evolution and assembly of ESCRTs. Biochem Soc Trans 37: 151-155, 2009.
60. Margulis L: Genome acquisition in horizontal gene transfer: symbiogenesis and macromolecular sequence analysis. Methods Mol Biol 532: 181-191, 2009.
61. Fuerst JA and Webb RI: Membrane-bounded nucleoid in the eubacterium Gemmata obscuriglobus. Proc Natl Acad Sci USA 88: 8184-8188, 1991.
62. Lee K-C, Webb RI and Fuerst JA: The cell cycle of the planctomycete Gemmata obscuriglobus with respect to cell compartmentalization. BMC Cell Biol 10: 45, 2009.
63. Lindsay MR, Webb RI, Strous M, Jetten MS, Butler MK, Forde RJ and Fuerst JA: Cell compartmentalization in planctomycetes: novel types of structural organization for the bacterial cell. Arch Microbiol 175: 413-429, 2001.
64. Jenkins C, Kedar V and Fuerst JA: Gene discovery within the planctomycete division of the domain Bacteria using sequence tags from genomic DNA libraries. Genome Biol 3: 6, 2002.
65. Bauer M, Lombardot T, Teeling H, Ward NL. Amann RI and Glockner FO: Archaea-like genes for C1-transfer enzymes in Planctomycetes: phylogenetic implications of their unexpected presence in this phylum. J Mol Evol 59: 571-586, 2004.
66. Lieber A, Leis A, Kushmaro A, Minsky A and Medalia O: Chromatin organization and radio resistance in the bacterium Gemmata obscuriglobus. J Bacteriol 191: 1439-1445, 2009.
67. Kulichevskaya IS, Baulina OI, Bodelier PL, Rijpstra WI, Damsté JS and Dedysh SN: Zavarzinella formosa gen. nov., sp. nov., a novel stalked Gemmata-like planctomycete from a Siberian peat bog. Int J Syst Evol Microbiol 59: 357-364, 2009.
68. Chatterjee AG, Leem YE, Kelly FD and Levin HL: The chromodomain of Tf1 integrase promotes binding to cDNA and mediates target site selection. J Virol 83: 2675-2685, 2008.
69. Nefedova LN and Kim AI: Molecular evolution of mobile elements of the gypsy group: a homolog of the gag gene in Drosophila (in Russian). Genetika 45: 30-37, 2009.
70. Gorinsek B. Gubensek F and Kordis D: Evolutionary genomics of chromovirus in Eukaryotes. Mol Biol Evol 21: 781-798, 2004.
71. Gorinsek B, Gubensek F and Kordis D: Phylogenomic analysis of chromoviruses. Cytogenet Genome Res 110: 543-552, 2005.
72. Nefedova LN and Kim AI: Evolution from retrotransposon to retroviruses: origin of the env gene. Zh Obshch Biol 68: 459-467, 2007.
73. Kordis D: A genomic perspective on the chromodomain-containing retrotransposons, chromoviruses. Gene 347: 161-173, 2005.
74. Wada H and Satoh N: Details of the evolutionary history from invertebrates to vertebrates, as deduced from the sequences of 18S rDNA. Proc Natl Acad Sci USA 91: 1801-1804, 1994.
75. Ayala FJ, Rzhetsky A and Ayala FJ: Origin of the metazoan phyla: molecular clocks confirm paleontological estimates. Proc Natl Acad Sci USA 95: 606-611, 1998.
76. Miller K, Lynch C, Martin J, Herniou E and Tristem M: Identification of multiple Gypsy LTR-retrotransposon lineages in vertebrate genomes. J Mol Evol 49: 358-366, 1999.
77. Takatori N and Saiga H: Evolution of CUT class homeobox genes: insights from the genome of the amphioxus, Branchiostoma floridae. Int J Dev Biol 52: 969-977, 2008.
78. Llorens C, Fares MA and Moya A: Relationship of gag-pol diversity between Ty3/Gypsy and Retroviridae LTR retroelements and the three kings hypothesis. BMC 8: 279-301, 2006
79. Gao X, Hou Y, Ebina H, Levin HL and Voytas DF: Chromodomains direct integration of retrotransposons to heterochromatin. Genome Res 18: 359-369, 2008.
80. Bushman F: Lateral DNA Transfer. Cold Spring Harbor Laboratory Press Cold Spring Harbor, New York, NY, pp1-448, 2002.
81. Malik HS and Eickbush TH: Molecular evolution of the integrase domain in the Ty3/Gypsy class of LTR retrotransposons. J Virol 73: 5186-5190, 1999.
82. Danchin EG and Pontarotto P: Statistical evidence for a more than 800-million year-old evolutionarily conserved genomic region in our genome. J Mol Evol 59: 587-597, 2004.
83. Stanhope MJ, Lupas A, Italia MJ, Koretke KK, Volker C and Brown JR: Phylogenetic analyses do not support horizontal gene transfers from bacteria to vertebrates. Nature 411: 940-944, 2001.
84. Bannert N and Kurth R: Retroelements and the human genome: new perspectives on an old relation. Proc Natl Acad Sci USA 191 (Suppl. 2): 14572-14579, 2004.
85. Sinkovics JG: Retroviruses R us. Hung Venerol Archiv V/4: 231-233, 2002.
86. Brady T, Lee YN, Ronen K, Malani N, Berry CC, Bieniasz PD and Bushman FD: Integration target site selection by a resurrected human endogenous retrovirus. Genes Dev 23: 633-642, 2009.
87. Serafino A, Balesrieri E, Piermarchi P, Matteucci C, Moroni G, Oricchio E, Rasi G, Mastino A, Spadafora C, Garaci E and Vallebona PS: The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation. Exp Cell Res 315: 849-862, 2009.
88. Sinkovics JG and Horvath JC: Criminal collusion of herpes-and retro(lenti)viruses. Hung Venerol Archiv IV: 105, 2000.
89. Tinari A, Superti F, Ammendolia MG, Chiozzini C, Hohenadi C, Leone P, Nappi F, Nicoletti M, Borsetti A, Marchetti M, Ensoli B and Monini P: Primary effusion lymphoma cells undergoing human herpesvirus type 8 productive infection produce C-type retroviral particles. Int J Immunopathol Pharmacol 21: 999-1006, 2008.
90. Geuking MB, Weber J, Dewannieux M, Gorelik E, Heidmann T, Hengartner H Zinkernagel RM and Hengartner L: Recombination of retrotransposon and exogenous RNA virus results in non-retroviral cDNA integration. Science 323: 393-396, 2009.
91. Kasahara M, Kasamatsu J and Sutoh Y: Two types of antigen receptor systems in vertebrates. Zoolog Sci 25: 969-975, 2008.
92. Kim HM, Oh SC, Lim KJ, Kasamatsu J, Heo JY, Park BS, Lee H, Yoo OJ, Kasahara M and Lee JO: Structural diversity of the hagfish variable lymphocyte receptors. J Biol Chem 282: 6726-6732, 2007.
93. Ishii A, Matsuo A, Sawa H, Tsujita T, Shida K, Matsumoto M and Seya T: Lamprey TLRs with properties distinct from those of the variable lymphocyte receptors. J Immunol 178: 397-406, 2007.
94. Alder MN, Rogozin IB, Iyer LM, Glatzko GV, Cooper MD and Pancer Z: Diversity and function of adaptive immune receptors in a jawless vertebrate. Science 310: 1970-1973, 2005.
95. Herrin BR, Alder MN, Roux KH, Sina C, Ehrhardt GR, Boydston JA, Turnbough CL Jr and Cooper MD: Structure and specificity of lamprey monoclonal antibodies. Proc Natl Acad Sci USA 105: 2040-2045, 2008.
96. Pancer Z, Saha NR, Kasamatsu J, Suzuki T, Amemiya CT, Kasahara M and Cooper MD: Variable lymphocyte receptors in hagfish. Proc Natl Acad Sci USA 102: 9224-9229, 2005.
97. Huang S, Yuan S, Guo L, Yu Y, Li J, Wu T, Liu T, Yang M, Wu K, Liu H, Ge J, Yu Y, Huang H, Dong M, Yu C, Chen S and Xu A: Genomic analysis of the immune gene repertoire of amphioxus reveals extraordinary innate complexity and diversity. Genome Res 18: 1112-1126, 2008.
98. Holland LZ, Alabaklat R, Azumi K, Benito-Gutiérrez E, Blow MJ, Bronner-Fraser M, Brunet F, Butts T, Candiani S, Disaw LJ, Ferrier DE, Garcia-Fernàndez J, Gibson-Brown JJ, Gissi C, Godzik A, Hallböök, F, Hirose D, et al: The amphioxus genome illuminates vertebrate origin and cephalochordate biology. Genome Res 18: 1100-1111, 2008.
99. Ferrier DE and Holland PW: Ancient origin of the Hox gene cluster. Nat Rev Genet 2: 33-38, 2001.
100. Kimura A, Sakaguchi E and Nonaka M: Multi-component system of Cnidaria: C3, Bf, and MASP genes expressed in the endodermal tissues of a sea anemone, Nematostella vectensis. Immunobiology 214: 165-178, 2009.
101. Hibino T, Loza-Coll M, Messier C, Majeske AJ, Cohen AH, Terwilliger DP Buckley KM, Brockton V, Nakir SV, Berney K, Fugmann SD, Anderson MK, Pancer Z, Cameron RA, Smith LC and Rast JP: The immune gene repertoire encoded in the purple sea urchin genome. Dev Biol 300: 349-365, 2006.
102. Müller WE, Schröder HC, Skorokhod A, Bünz C, Müller IM and Grebenjuk VA: Contribution of sponge genes to unravel the genome of the hypothetical ancestor of Metazoa (Urmetazoa). Gen 276: 161-173, 2001.
103. Nonaka M and Yoshizaki F: Primitive complement system of invertebrates. Immunol Rev 198: 203-215, 2004.
104. Kubrycht J, Sigler K, Ruzicka M, Soucek P, Borecky J and Jezek P: Ancient phylogenetic beginnings of immunoglobulin hypermutation. J Mol Evol 63: 691-706, 2006.
105. Cooper MD and Alder MN: The evolution of adaptive immune systems. Cell 124: 815-822, 2006.
106. Pancer Z and Cooper MD: The evolution of adaptive immunity. Annu Rev Immunol 24: 497-518, 2006.
107. Bernstein RM, Schluter SF, Lake DF and Marchalonis JJ: Evolutionary conservation and molecular cloning of the recombinase activating gene 1. Biochem Biophys Res Commun 205: 687-692, 1994.
108. Bernstein RM, Schluter SF, Bernstein H and Marchalonis JJ: Primordial emergence of the recombination activating gene 1 (RAG 1): sequence of the shark gene indicates homology to microbial integrases. Proc Natl Acad Sci USA 93: 9454-9459, 1996.
109. Agrawal A, Eastman QM and Schatz DG: Transposition mediated by RAG 1 and RAG 2 and its implications for the evolution of the immune system. Nature 394: 744-751, 1998.
110. Marchalonis JJ, Jensen I and Schluter SF: Structural, antigenic and evolutionary analyses of immunoglobulins and T cell receptors. J Mol Recognit 15: 260-271, 2002.
111. Hiom K, Melek M and Gellert M: DNA transposition by the RAG 1 and RAG 2 proteins: a possible source of oncogenic translocations. Cell 94: 463-470, 1998.
112. Van Gent DC, Mizuuchi K and Gellert M: Similarities between initiation of V(D)J recombination and retroviral integration. Science 271: 1592-1594, 1996.
113. Rogozin IB, Iyer LM, Liang L, Glazko GV, Liston VG, Pavlov YI, Aravind L and Pancer Z: Evolution and diversification of lamprey antigen receptors: evidence for involvement of an AID-APOBEC family cytosine deaminase. Nat Immunol 8: 647-656, 2007.
114. Villarreal LP: The source of self: genetic parasites and the origin of adaptive immunity. Ann NY Acad Sci (In press).
115. Dreyfus DH, Nagasawa M, Kelleher CA and Gelfand EW: Stable expression of Epstein-Barr virus BZLF-1 encoded ZEBRA protein activates p53-dependent transcription in human Jurkat T-lymphoblastoid cells. Blood 96: 625-634, 2000.
116. Richards TA, Dacks JB, Campbell SA, Blanchard JL, Foster PG, McLeod R and Roberts CW: Evolutionary origin of the eukaryotic shikimate pathway: gene fusions, horizontal gene transfer, and endosymbiotic replacements. Eukaryot Cell 5: 1517-1531, 2006.
117. Starcevic A, Akthar S, Dunlap WC, Shick JM, Hranueli D, Cullum J and Long PF: Enzymes of the shikimic acid pathway encoded in the genome of basal metazoan, Nematostella vectensis, have microbial origins. Proc Natl Acad Sci USA 105: 2533-2537, 2008.
118. Heindl H, Wiese J and Imhoff JF: Tenacibaculum adriaticum sp. nov. from Bryozoan in the Adriatic Sea. Int J Syst Evol Microbiol 58: 542-547, 2008.
119. Wang JT, Chou Y, Chou JH, Chen CA and Chen WM: Tenacibaculum aiptasiae sp. nov. isolated from sea anemone Aiptasia pulchella. Int Syst Evol Microbiol 58: 761-766, 2008.
120. Egyed Z, Sréter T, Széll Z, Nyirö G, Márialigeti K and Varga I: Molecular phylogenetic analysis of Onchocerca lupi and its Wolbachia endosymbiont. Vet Parasitol 108: 153-161, 2002.
121. Rokas S, Atkinson RJ, Nieves-Aldrey JL, West SA and Stone GN: The incidence and diversity of Wolbachia in gallwasps (Hymenoptera; Cynipidae) on oak. Mol Ecol 11: 1815-1829, 2002.
122. Casiraghi M, Bordenstein SR, Baldo L, Lo N, Beninati T, Wernegreen JJ, Werren JH and Bandi C: Phylogeny of Wolbachia pipientis based on gltA, groE and ftsZ gene sequences: clustering of arthropod and nematode symbionts in the F supergroup, and evidence for further diversity in the Wolbachia tree. Microbiology 151: 4015-4022, 2005.
123. Gompert Z, Forister ML, Fordyce JA and Nice CC: Widespread mito-nuclear discordance with evidence for introgressive hybridization and selective sweeps in Lycaeides. Mol Ecol 17: 5231-5244, 2008.
124. Kumm S and Moritz G: First detection of wolbachia in arrhenotokous populations of thrips species (Thysanoptera: thripidae and phlaeothripidae) and its role in reproduction. Environ Entomol 37: 1422-1428, 2008.
125. Cordaux R, Pichon S, Ling A, Pérez P, Deaunay C, Vavra F, Bouchon D and Grève P: Intense transpositional activity of insertion sequences in an ancient obligate endosymbiont. Mol Biol Evol 25: 1889-1896, 2008.
126. Moran NA, McCutcheon JP and Nakabachi A: Genomics and evolution of heritable bacterial symbionts. Annu Rev Genet 42: 165-190, 2008.
127. Woolfit M, Iturbe-Ormaetxe I McGraw EA and O'Neill SL: An ancient horizontal gene transfer between mosquito and the endosymbiotic bacteium Wolbachia pipientis. Mol Biol Evol 26: 367-374, 2008.
128. Raychoudhury R, Bald L, Oliveira DC and Werren HJ: Modes of acquisition of Wolbachia: horizontal transfer, hybrid introgression, and codivergence in the Nasonia species complex. Evolution 63: 165-183, 2009.
129. Rumpho ME, Worful JM, Lee J, Kannan K, Tyler MS, Bhatacharya D, Moustafa A and Manhart JRL: Horizontal gene transfer of the algal nuclear gene psbO to the photosynthetic seaslug Elysia chlorotica. Proc Natl Acad Sci USA 105: 17867-17871, 2008.
130. Pierce SK, Maugel TJK, Rumpho ME, Hanten JJ and Mondy WL: Annual viral expression in sea slug population: life cycle control and symbiotic chloroplast maintenance. Biol Bull 197: 1-6, 1999.
131. Nudson WA, Rovnak J, Buechner M and Quackenbush SL: Walleye dermal sarcoma virus Orf C is targeted to the mitochondria. J Gen Virol 84: 375-381, 2003.
132. Paul TA, Quackenbush SL, Sutton C, Casey RN, Bowser PR and Casey JW: Identification and characterization of an exogenous retrovirus from atlantic salmon swim bladder sarcoma. J Virol 80: 2941-2948, 2006.
133. Ribet D, Louvet-Vallée S, Harper F, De Parseval N, Dewannieux M, Heidmann O, Pierron G, Maro B and Heidmann T: Murine endogenous retrovirus MuERV-L is the progenitor of the orphan: epsilon viruslike particles in the early mouse embryo. J Virol 82: 1622-1625, 2007.
134. Quackenbush SL, Linton A, Brewster CD and Rovnak J: Walleye dermal sarcoma virus rv-cyclin inhibits NF-kappaB-dependent transcription. Virology 386: 55-60, 2009.
135. Sinkovics JG: Adult human sarcomas. I. Basic science. Expert Rev Anticancer Ther 7: 31-56, 2007.
136. Sinkovics JG: Adult human sarcomas. II. Medical oncology. Expert Rev Anticancer Ther 7: 183-210, 2007
137. Sinkovics JG: Comments on cultured human sarcoma cells. Sarcoma 7: 75-77, 2003.
138. Charytonowicz E, Cordo-Cardo C, Matushansky I and Ziman M: Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell? Cancer Lett 279: 126-136, 2009.
139. Cironi L, Riggi N, Provero P, Wolf N, Suvá ML, Suvá D, Kindler V and Stamenkovic I: IGF1 is a common target gene of Ewing's sarcoma fusion proteins in mesenchymal progenitor cells. PublicLibrary Science PLoS ONE 3: e2634, pp1-22, 2008.
140. Padilla-Rodriguez AL, Bembassat M, Lazaro M and Ortiz-Hidalgo C: Intra-abdominal follicular dendritic cell sarcoma with marked pleomorphic features and aberrant expression of neuroendocrine markers: report of a case with immunohistochemical analysis. Appl Immunohistochem Mol Morph 15: 346-352, 2007.
141. Huang SC, Chang CL, Huang CH and Chang CC: Histiocytic sarcoma - a case with evenly distributed multinucleated giant cells. Pathol Res Pract 20: 683-689, 2007.
142. Gosh A, Dwiwedi US and Kumar A: Inflammatory malignant fibrous histiocytoma of kidney: a case report. Pathol Res Pract 204: 857-861, 2008.
143. Sourvinos G, Tsatsanis C and Spandidos DA: Mechanisms of retrovirus-induced oncogenesis. Folia Biol 46: 226-232, 2000.
144. Maeda N, Fan H and Yoshikai Y: Oncogenesis by retroviruses: old and new paradigms. Rev Med Virol 18: 387-405, 2008.
145. Nieto MA, Bennett MF, Sargent MG and Wilinson DG: Cloning and developmental expression of Sna, a murine homologue of the Drosophila snail gene. Development 116: 227-237, 1992.
146. Hammerschmidt M and Nüssein-Volhard C: The expression of a zebrafish gene homologous to Drosophila snail suggests a conserved function in invertebrate and vertebrate gastrulation. Development 119: 1107-1118, 1993.
147. Fukiwara S, Corbo JC and Levine M: The snail repressor establishes a muscle/notochord boundary in the Ciona embryo. Development 125: 2511-2520, 1998.
148. Fritzenwanker JH, Saina M and Technau U: Analysis of forkhead and snail expression reveals epithelial-mesenchymal transitions during embryonic and larval development of Nematostella vectensis. Dev Biol 275: 389-402, 2004.
149. Blanco MJ, Barrallo-Gimeno A, Acloque H, Reyes AE, Tada M, Allende ML, Mayor R and Nieto MA: Snail1a and Snail1b cooperate in the anterior migration of the axial mesoderm in the zebrafish embryo. Development 134: 4073-4081, 2007.
150. Barrallo-Gimeno A and Nieto MA: The snail genes as inducers of cell movement and survival: implications in development and cancer. Development 132: 3151-3161, 2005.
151. Lee SH, Lee SJ, Jung YS, Xu Y, Kang HS, Ha NC and Park BJ: Blocking of p53 Snail binding, promoted by oncogenic K-Ras, recovers p53 expression and function. Neoplasia 11: 22-31, 2009.
152. Horiguchi K, Shirakihara T, Nakano A, Imamura T, Miyazono K and Saitoh M: Role of Ras signaling in the induction of snail by transforming growth factor-beta. J Biol Chem 284: 245-253, 2009.
153. Medici D, Hay ED and Goodenough DA: Cooperation between snail and LEF-1 transcription factors is essential for TGF-beta 1-induced epithelial-mesenchymal transition. Mol Biol Cell 17: 1871-1879, 2006.
154. Massoumi R, Kuphal S, Hellerbrand C, Haas B, Wild P, Spruss T, Pfeiffer A, Fässler R and Bosserhoff AK: Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma. J Exp Med 206: 221-231, 2009.
155. Palmer MB, Majumder P, Cooper JC, Yoon H, Wade PA and Boss JM: Yin yang 1 regulates the expression of snail through a distal enhancer. Mol Cancer Res 7: 221-229, 2009.
156. Huang W, Zhang Y, Varambally S, Chinnalyan AM, Banerjee M, Merajver SD and Kleer CG: Inhibition of CCN6 (Wnt-1-induced signaling protein 3) down-regulates E-cadherin in the breast epithelium through induction of snail and ZEB1. Am J Pathol 172: 893-904, 2008.
157. Stemmer V, De Craene B, Berx G and Behrens J: Snail promotes Wnt target gene expression and interacts with beta-catenin. Oncogene 27: 5075-5080, 2008.
158. Yamasaki H, Sekimoto T, Ohkubo T, Douchi T, Nagata Y, Ozawa M and Yoneda Y: Zinc finger domain of Snail functions as a nuclear localization signal for importin beta-mediated nuclear import pathway. Genes Cells 10: 455-464, 2005.
159. Pon YL, Zhou HY, Cheung AN, Ngan HY and Wong AS: p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells. Cancer Res 68: 6524-6532, 2008.
160. Hoek K, Rimm DL, Williams KR, Zhao H, Aeiyan S, Lin A, Kluger HM Berger AJ, Cheng E, Trombetta ES, Wu T, Niiniobe M, Yoshikawa K, Hannigan GE and Halaban R: Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res 64: 5270-5282, 2004.
161. Paznekas WA, Okajima K, Schertzer M, Wood S and Jabs EW: Genomic organization, expression, and chromosome localization of the human SNAIL gene (SNAI1) and a related processed pseudogene (SNAI1P). Genomics 62: 42-49, 1999.
162. Twigg SR and Wilkie AO: Characteization of the human snail (SNAI1) gene and exclusion as a major disease gene in craniosyntosis. Hum Genet 105: 320-326, 1999.
163. Medici D, Hay ED and Olsen BR: Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. Mol Biol Cell 19: 4875-4887, 2008.
164. Nie J and Sage EH: SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling. J Biol Chem 284: 1279-1290, 2009.
165. Barker TH, Baneyx G, Cardo-Vila M, Workman GA, Weaver M, Menon PM, Dedhar S, Rempel SA, Arap W, Pasqualini R, Vogel V and Sage EH: SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity. J Biol Chem 280: 36483-36493, 2005.
166. Kataoka H, Murayama T, Yokoda M, Mori S, Sano H, Ozaki H, Yokota Y, Nishikawa S and Kita T: A novel snail-related transcription factor Smuc regulates basic helix-loop-helix transcription factor activities via specific E-box motifs. Nucleic Acids Res 28: 626-633, 2000.
167. Lopez D, Niu G, Huber C and Carter WB: Tumor-induced upregulation of Twist, Snail, and Slug represses the activity of the human VE-cadherin promoter. Arch Biochem Biophys 482: 77-82, 2009.
168. Sturm RA, Satyamoorty K, Meier F, Gardiner BB, Smit DJ, Vaidya B and Herlyn M: Osteonectin/SPARC induction by ectopic beta(3) integrin in human radial growth phase primary melanoma cells. Cancer Res 62: 226-232, 2002.
169. Brigstock D, Goldschmeding R, Katsube KI, Lam SC, Lau LF, Lyons K, Naus C, Perbal B, Riser B, Takigawa M and Yeger H: Proposal for a unified CCN nomenclature. Mol Pathol 56: 127-128, 2003.
170. Yeger H and Perbal B: The CCN family of genes: a perspective on CCN biology and therapeutic potential. J Cell Commun Signal 1: 159-164, 2007.
171. Fukunaga-Kalabis M, Martinez G, Telson SM, Liu ZJ, Balint K, Juhasz I, Elder DE, Perbal B and Herlyn M: Downregulation of CCN3 expression as a potential mechanism for melanoma progression. Oncogene 27: 2552-2560, 2008.
172. Sangaletti S, Di Carlio E, Gariboldi S, Miotti S, Cappetti B, Patenza M, Rumio C, Brekken RA, Chiodini C and Colombo MP: Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis. Cancer Res 68: 9050-9059, 2008.
173. Alvarez MJ, Prada F, Salvatierre E, Bravo AI, Lutzky VP, Carbone C, Pitossi FJ, Chuluyan HE and Podhajcer OL: Secreted protein acidic and rich in cysteine produced by human melanoma cells modulates polymorphonuclear leukocyte recruitment and antitumor cytotoxic capacity. Cancer Res 65: 5123-5132, 2005.
174. Sosa M, Girotti MR, Salvatierra E, Prada F, De Olmo JA, Gallango SJ, Albar JP, Podhajcer OL and Liera AS: Proteomic analysis identified N-cadherin, clusterin, and HSP27 as mediators of SPARC (secreted protein, acidic and rich in cysteine) activity in melanoma cells. Proteomics 7: 4123-4134, 2007.
175. Haber CL, Gottifredi V, Liera AS, Salvatiera E, Prada F, Alonso L, Sage EH and Podhajcer OL: SPARC modulates the proliferation of stromal but not melanoma cells unless endogenous SPARC expression is downregulated. Int J Cancer 122: 1465-1475, 2008.
176. Seno T, Harada H, Kohno S, Teraoka M, Inoue A and Ohnishi T: Downregulation of Sparc expression inhibits cell migration and invasion in malignant gliomas. Int J Oncol 34: 707-715, 2009.
177. Said N, Najwer I and Motamed K: Secreted protein acidic and rich in cysteine (SPARC) inhibits integrin-mediated adhesion and growth factor-dependent survival signaling in ovarian cancer. Am J Pathol 170: 1054-1063, 2007.
178. Tai IT and Tang MJ: SPARC in cancer biology: its role in cancer progression and potential for therapy. Drug Resist Updat 11: 231-246, 2008.
179. Hrabchak C, Ringuette M and Woodhouse K: Recombinant mouse SPARC promotes parietal endoderm differentiation and cardiomyogenesis in embryoid bodies. Biochem Cell Biol 86: 487-499, 2008.
180. Jinushi N, Nakazaki Y, Carrasco DR, Draganov D, Souders N, Johnson M, Mihm MC and Dranoff G: Milk fat globule EGF-8 promotes melanoma progression through coordinated Akt and twist signaling in the tumor microenvironment. Cancer Res 68: 8889-8898, 2008.
181. Horikawa T, Yang J, Kondo S, Yoshizaki T, Joab I, Furukawa M and Pagano JS: Twist and epithelial-mesenchymal transition are induced by EBV oncoprotein latent membrane protein 1 and II are associated with metastatic nasopharyngeal carcinoma. Cancer Res 57: 1970-1978, 2007.
182. Sinkovics JG: Hodgkin's disease revisited: Red-Sternberg cells as natural hybridomas. Crit Rev Immunol 11: 33-63, 1991.
183. Küppers R, Bräuninger A, Müschen M, Distler V, Hansmann M-L and Rajewsky K: Evidence that Hodgkin and Reed-Sterberg cells in Hodgkin's disease do not represent cell fusions. Blood 97: 818-821, 2001.
184. Gupta RK, Patel K, Bodmer WF and Bodmer JG: Mutations of p53 in primary biopsy material and cell lines from Hodgkin's disease. Proc Natl Acad Sci USA 90: 2817-2821, 1993.
185. Zucker-Franklin D: The role of human T cell lymphotropic virus type I tax in the development of cutaneous T cell lymphomas. Ann NY Acad Sci 941: 86-96, 2001.
186. Gross L: The Rauscher virus: a mixture of the Friend virus and the mouse leukemia virus (Gross)? Acta Haematol 35: 200-213, 1966.
187. Sinkovics JG, Drewinko B and Thornell E: Immunoresistant tetraploid lymphoma cells. Lancet 1: 139-140, 1970.
188. Sinkovics JG, Shirato E, Gyorkey F, Cabiness JR and Howe CD: Relationship between lymphoid neoplasms and immunologic functions. In: Leukemia-Lymphoma. Year Book Medical Publishers, Chicago, IL, pp53-92, 1970.
189. Sinkovics JG: The earliest concept of the 'hybridoma principle' recognized in 1967-68. Front Rad Ther Oncol 24: 18-31, 1990.
190. Sinkovics JG: A notable phenomenon recapitulated. Fusion product of a murine lymphoma cell and a leukemia virus-neutralizing antibody-producer host plasma cell formed spontaneously and secreting the specific antibody continuously. Acta Microbiol Immunol Hung 52: 1-40, 2005.
191. Sinkovics JG: The first observation (in the late 1960s) of fused lymphoid cells continuously secreting a specific antibody. Bull Mol Med 26: 61-80, 2005.
192. Köhler G and Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495-497, 1975.
193. Wainwright M: Tha Sinkovics hybridoma. The discovery of the first 'natural hybridoma'. Perspect Biol Med 35: 372-379, 1992.
194. Sinkovics JG: Lymphoid cells in long-term cultures. Med Rec Ann 61: 50-56, 1968.
195. Trujillo JM, List-Young B, Butler JJ, Shullenberger CC and Gott C: Long-term culture of lymph node tissue from a patient with lymphocytic lymphoma. Nature 209: 310-311, 1966.
196. Trujillo JM, Butler JJ, Ahearn MJ, Shullenberger CC, List-Young B, Gott C, Anstall HB and Shively JA: Long-term culture of lymph node tissue from a patient with lymphocytic lymphoma. II. Preliminary ultrastructural, immunofluorescence and cytogenetic studies. Cancer 20: 215-224, 1967.
197. De Baettseller P, Gotrelik E, Eshar Z, Ron Y, Katzav S, Feldman M and Segal S: Metastatic properties conferred on nonmetastatic tumors by hybridization of spleen B-lymphocytes with plasmacytoma cells. J Natl Cancer Inst 67: 1079-1087, 1981.
198. Chakraborty A, Lazova R, Davies S, Bäckvall H, Ponten F, Brash D and Pawelek J: Donor DNA in a renal carcinoma metastasis from a bone marrow transplant recipient. Bone Marrow Transplant 34: 183-186, 2004.
199. Yilmaz Y, Lazova R, Qumsiyeh M, Cooper D and Pawelek J: Donor Y chromosome in renal carcinoma cells of a female BMT recipient: visualization of putative BMT-tumor hybrids by FISH. Bone Marrow Transplant 35: 1021-1024, 2005.
200. Pawelek JM: Tumor-cell fusion as a source of myeloid traits in cancer. Lancet Oncol 6: 988-993, 2005.
201. Munzarová M and Kovarík J: Is cancer a macrophage-mediated autoaggressive disease? Lancet 1: 952-954, 1987.
202. Sinkovics JG and Horvath JC: Viral therapy of human cancers. Melanoma Res 13: 431-432, 2003.
203. Pawelek J, Chakraborty A, Lazovs R, Yilmaz Y, Cooper D, Brash D and Handerson T: Co-opting macrophage traits in cancer progression: a consequence of tumor cell fusion? In: Infection and Inflammation. Impacts on Oncogenesis. Dittmar T, Zaenker KS and Schmidt A (eds). Karger, Basel. Contrib Microbiol 13: 138-155, 2006.
204. Pawelek J and Chakraborty AK: The cancer cell-leukocyte fusion theory of metastasis. Adv Cancer Res 101: 397-444, 2008.
205. Pawelek JM and Chakraborty AK: Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis. Nat Rev Cancer 8: 377-386, 2008.
206. Weber EW, O'Day S, Rose M, Deck R, Ames P, Good J, Meyer J, Allen R, Trautvetter S, Timmermann M, Cruickshank S, Cook M, Gonzalez R and Spitler LE: Low-dose outpatient chemobiotherapy with temozolomid, granulocyte-macrophage colony stimulating factor, interferon-alpha2b, and recombinant interleukin-2 for the treatment of metastatic melanoma. J Clin Oncol 23: 8992-9000, 2005.
207. Daud AI, Mirza N, Lenox B, Andrews S, Urbas P, Gzao GX, Lee JH, Sondak VK, Riker AI, Deconti RC and Gabrilovich D: Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte-macrophage colony-stimulating factor. J Clin Oncol 26: 3235-3241, 2008.
208. Kirkwood JM, Lee S Moschos SJ, Albertini MR, Michalak JC, Sander C, Whiteside T, Butterfield LH and Weiner L: Immunogenicity and antitumour effects of vaccination with peptide vaccine/-granulocyte-monocyte colony-stimulating factor and/or IFNalpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696. Clin Cancer Res 15: 1443-1451, 2009.
209. Han D, Pottin-Clemenceau C, Imro MA, Scudeletti M, Doucet C, Puppo F, Brouty-Boye D, Vedrenne J, Sahraoui Y, Brailly M, Poggi A, Jasmin C, Azzarone B and Indiveri F: IL-2 triggers a tumor progression process in a melanoma cell line MELP derived from a patient whose metastasis increased in size during IL2/INFalpha biotherapy. Oncogene 12: 1015-1023, 1996.
210. Sinkovics JG: Malignant lymphoma arising from natural killer cells: report of the first case in 1970 and newer developments in the FasL.FasR system. Acta Microbiol Immunol Hung 44: 293-307, 1997.
211. Sinkovics JG and Horvath JC: Virological and immunological connotations of apoptotic and anti-apoptotic forces in neoplasia. Int J Oncol 19: 473-488, 2001. Erratum in Int J Oncol 27: 33, 2005.
212. Sinkovics JG and Horvath JC: Evidence accumulating in support of cancer vaccines combined with chemotherapy: a pragmatic review of past and present efforts. Int J Oncol 29: 765-777, 2006.
213. Takahashi T, Tanaka M, Ogasawa J, Suda T, Murakami H and Nagata S: Swapping between Fas and granulocyte colony-stimulating factor receptor. J Biol Chem 271: 17555-17560, 1996.
214. Shinohara H, Yagitya H, Ikawa Y and Oyaizu N: Fas drives cell cycle progression in glioma cells via extracellular signal regulated kinase activation. Cancer Res 60: 1766-1772, 2000.
215. Larizza L and Schirrmacher V: Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants. Cancer Met Rev 3: 193-222, 1984.
216. Busund LT, Killie MK, Bartnes K and Seljelid R: Spontaneously formed tumorigenic hybrids of Meth A sarcoma cells and macrophages in vivo. Int J Cancer 106: 153-159, 2003.
217. Prasolov V, Ivanov D, Hein S, Rutter G, Münk C, Löhler J and Stocking C: The Mus cervicolor MuLV isolate M813 is highly fusogenic and induces a T-cell lymphoma associated with large multinucleated cells. Virology 290: 39-49, 2001.
218. Pienta RJ, Fine DL, Hurt T, Smith CK, Landon JC and Chopra HC: Transformation of rhesus foreskin cells by Mason-Pfizer monkey virus. J Natl Cancer Inst 48: 1913-1917, 1972.
219. Duelli DM, Hearn S, Myers MP and Lazebnik Y: A primate virus generates transformed human cells by fusion. J Cell Biol 171: 493-503, 2005.
220. Vile R: Viral mediated cell fusion: viral fusion - the making or breaking of a tumor? Gene Ther 13: 1127-1130, 2006.
221. Duelli DM, Padilla-Nash HM, Berman D, Murphy KM, Ried T and Lazebnik Y: A virus causes cancer by inducing massive chromosomal instability through cell fusion. Curr Biol 17: 431-437, 2007.
222. Sinkovics JG, Groves GF and Howe CD: Actions of interferon in tissue cultures harboring mouse leukemia virus. Experientia 24: 927-928, 1968.
223. Muster T, Waltenberger A, Grassauer A, Hirschl S, Caucig P, Romireer I, Födinger D, Seppele H, Scanab O, Magin-Lachman C, Löwer R, Jansen B, Pehamberger H and Wolff K: An endogenous retrovirus derived from human melanoma cells. Cancer Res 63: 8735-8741, 2003.
224. Dewannieux M, Blaise S and Heidmann T: Identification of a functional envelope protein from the HERV-K family of human endogenous retroviruses. J Virol 79: 15573-15577, 2005.
225. Moreno M, Molling JW, von Mensdorff-Pouilly S, Verheijen RH, Hooijberg E, Kramer D, Reurs AW, van der Eartwegh AJ, von Blomberg BM, Scheper RJ and Bontkes HJ: IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses. J Immunol 181: 2446-2454, 2008.
226. Mangeney M and Heldmann T: Tumor cells expressing a retroviral envelope escape immune rejection in vivo. Proc Natl Acad Sci USA 95: 14920-14925, 1998.
227. Holmgren L, Szeles A, Rajnavölgyi E, Folkman J, Klein G, Ernberg I and Falk KI: Horizontal transfer of DNA by the uptake of apoptotic bodies. Blood 93: 3956-3963, 1999.
228. Jiang H, Whte EJ, Conrad C, Gomez-Manzano C and Fueyo J: Autophagy pathways in glioblastoma. Methods Enzymol 453: 273-286, 2009.
229. Ulasov IV, Tyler MA, Zhu ZB, Han Y, He TC and Lesniak MS: Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy. Int J Oncol 34: 729-742, 2009.
230. Ge P, Luo Y, Fu S, Ji X and Ling F: Autophagy: a strategy for malignant glioma's resistance to therapy. Med Hypotheses 73: 45-47, 2009.
231. Latimer AJ and Jessen JR: Hgf/c-met expression and functional analysis during zebrafish embryogenesis. Dev Dyn 237: 3904-3915, 2008.
232. Tempest PR, Reevs BR, Spurr NK, Rance AJ Chan AM and Brookes P: Activation of the met human MNNG-HOS cell line involves a chromosomal rearrangement. Carcinogenesis 7: 2051-2057, 1986.
233. Oda Y, Matsumo Y, Hariyama K, Iwamoto Y and Tsuneyoshi M: Establishment of new multidrug-resistant human osteosarcoma cell lines. Oncol Rep 7: 859-866, 2000.
234. Mori K, Le Goff B, Berreur M, Riet A, Moreau A, Blanchard F, Chevalier C, Guisie-Marsollier I, Léger J, Guicheux J, Masson M, Gouin F, Rédini F and Heymann D: Human osteosarcoma cells express functional receptor activator of nuclear factor-kappaB. J Pathol 211: 555-562, 2007.
235. Dedhar S and Saulnier R: Alterations in integrin receptor expression on chemically transformed human cells: specific enhancement of laminin and collagen receptor complexes. J Cell Biol 110: 481-489, 1990.
236. Voisey J, Carroll L and van Daal A: Melanocortins and their receptors and antagonists. Curr Drug Targets 4: 586-597, 2003.
237. Shibahara S, Taked K, Yasumoto K, Udono T, Watanabe KM, Saito H and Takahashi K: Microphthalmia-associated transcription factor (MITF): multiplicity in structure, function, and regulation. J Investig Dermatol Symp Proc 6: 99-104, 2001.
238. Steingrimsson E, Copeland NG and Jankins NA: Melanocytes and the microphthalmia transcription factor network. Annu Rev Genet 38: 365-411, 2004.
239. De la Serna IL, Ohkawa Y, Higashi C, Dutta C, Osias J, Kommajosyula N, Tachibana T and Imbalzano AN: The microphthalmia-associated transcription factor requires SWI/SNF enzymes to activate melanocyte-specific genes. J Biol Chem 281: 20233-20241, 2006.
240. Kitago M, Koyanagi K, Nakamura T, Goto Y, Faries M, O'Day SJ, Morton DL, Ferrone S and Hoon DS: mRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanoma-associated antigen-specific monoclonal antibody beads. Clin Chem 55: 757-764, 2009.
241. Knudson AG Jr: Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820-823, 1971.
242. Imreh S, Klein G and Zabarovsky ER: Search for unknown tumor-antagonizing genes. Genes Chromosomes Cancer 38: 307-321, 2003.
243. Sinkovics JG and Horvath JC (authors/eds): Viral Therapy of Human Cancers. Marcel Dekker, New York, NY, pp1-829, 2005.
244. Sinkovics JG and Horvath JC: Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers. Arch Immunol Ther Exp 56: S3-S59, 2008.
245. Oh JJ, Boctor Bn, Jimenez CA, Lopez R, Koegel AK, Taschereau EO, Phan DT, Jacobsen SE and Slamon DJ: Promoter methylation study of he H37/RBM5 tumor suppressor gene from the 3p31.3 human lung cancer tumor suppressor locus. Hum Genet 123: 55-64, 2007.
246. Rachkovsky M, Sodi S, Chakraborty A, Avissar Y, Bolognia J, McNiff JM, Platt J, Bermudes D and Pawelek J: Melanoma × macrophage hybrids with enhanced metastatic potential. Clin Exp Metastasis 16: 299-312, 1998.
247. Copeman MC and Harris H: The extracellular matrix of hybrids between melanoma cells and normal fibroblasts. J Cell Sci 91: 281-286, 1988.
248. Harris H: The biology of tumour suppression. Ciba Found Symp 142: 199-206, 1989.
249. England NL, Cuthbert AP, Trott DA, Jezzard S, Nobori T, Carson DA and Newbold RF: Identification of human suppressor genes by monochromosome transfer: rapid growth-arrest response mapped to 9p21 is mediated solely by the cyclin-D-dependent kinase inhibitor gene, CDKN2A (p16INK4A). Carcinogenesis 17: 1567-1575, 1996.
250. Yagi M, Miyamoto T, Sawatani Y, Iwamoto K, Fujita N, Morita K, Ninomiya K, Suzuki T, Miyamoto K, Oike Y, Takeya M, Toyama Y and Suda T: DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant clls. J Exp Med 202: 345-351, 2005.
251. Andersen TL, Boissy P, Sondergaard TE, Kupisiewicz K, Plesner T, Rasmussen T, Haaber J, Kølvraa S and Delaissé JM: Osteoclast nuclei of myeloma patients show chromosome translocations specific for the myeloma cell clone: a new type of cancer-host partnership? J Pathol 211: 10-17, 2007.
252. Hecht M, von Metzler I, Sack K, Kaiser M and Sezer O: Interactions of myeloma cells with osteoclasts promote tumour expansion and bone degradation through activation of a complex signaling network and upregulation of cathepsin K, matrix metalloproteinases (MMPs) and urokinase plasminogen activator (uPA). Exp Cell Res 314: 1082-1093, 2008.
253. Park JY, Bas MA, Cheon HG, Kim SS, Hong JM, Kim TH, Choi JY, Kim SH, Lim J, Choi CH, Shin HI, Kim SY and Park EK: A novel PPARgamma agonist, KR62776, suppresses RANKL-induced osteoclast differentiation and activity by inhibiting MAP kinase pathways. Biochem Biophys Res Commun 378: 645-649, 2009.
254. Soysa NS, Alles N, Shiokawa H, Jimi E, Aoki K and Ohya K: Inhibition of the classical NF-kappaB pathway prevents osteoclast bone-resorbing activity. J Bone Miner Metab 27: 131-139, 2009.
255. 12O-tetra decanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation. J Bone Miner Res 18: 2159-2168, 2003.
256. Boissy P, Andersen TL, Abdallah BM, Kassem M, Plesner T and Dalassé JM: Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation. Cancer Res 65: 9943-9952, 2005.
257. Chen EH, Grote E, Mohler W and Vignery A: Cell-cell fusion. Federation European Biological Societies. FEBS Lett 581: 2181-2193, 2007.
258. Podbilewicz B: Cell fusion. WormBook 6: 1-32, 2006.
259. Abmayr SM, Zhuang S and Geisbrecht ER: Myoblast fusion in Drosophila. Methods Mol Biol 475: 75-97, 2008.
260. Estrada B and Michelson AM: A genomic approach to myoblast fusion in Drosophila. Methods Mol Biol 475: 299-314, 2008.
261. Duan W, Qin Q, Chen S, Liu S, Wang J, Zhang C, Sun Y and Liu Y: The formation of improved tetraploid population of red crucian carp × common carp hybrids by androgenesis. Sci China Life Sci 50: 753-761, 2007.
262. Szczerbakowa A, Maciejewska U, Zimnoch-Guzowska E and Wielgat B: Somatic hybrids Solanum nigrum (+) S. tuberosum: morphological assessment and verification of hybridity. Plant Cell Rep 21: 577-587, 2003.
263. Przetakiewicz J, Nadolska-Orczyk A, Kuc D and Orczyk W: Tetraploid somatic hybrids of potato (Solanum tuberosum L.) obtained from diploid breeding lines. Cell Mol Biol Lett 12: 253-267, 2007.
264. Marveeva NA, Hakhoskii AM and Kuchuk NV: Somatic hybrids among transgenic Solanum tuberosum and transplastomic Solanum Rickii. Tsitol Genet 42: 38-44, 2008.
265. Knyihár E: Myoepithelial nexus. Intercellular membrane fusion in the dilator pupillae muscle. Acta Biol Acad Sci Hung 22: 351-360, 1971.
266. Lawrence JB and Coleman JR: Extinction of muscle-specific properties in somatic cell heterokaryons. Dev Biol 101: 4463-4476, 1984.
267. Tam SK, Gu W, Mahdavi V and Nadal-Ginard B: Cardiac myocyte terminal differentiation. Potential for cardiac regeneration. Ann NY Acad Sci 752: 72-79, 1995.
268. Yagami-Hirosama T, Sato T, Kurisaki T, Kamijo K, Nabeshima Y and Fujisawa Sehara A: A metalloproteinase-disintegrin participating in myoblast fusion. Nature 377: 652-656, 1995.
269. Menzorov AG, Matveeva NM, Larkin DM, Zaykin DV and Servo OL: Fate of parental mitochondria in embryonic stem hybrid cells. Tsitologiia 50: 711-718, 2008.
270. Motensen K, Lichtenberg J, Thomsen PD and Larsson LT: Spontaneous fusion between cancer cells and endothelial cells. Cell Mol Life Sci 61: 2125-2131, 2004.
271. Döme B, Tímár J, Dobos J, Mészáros L, Raso E, Paku S, Kenessey I, Ostoros G, Magyar M, Lad-acanyi A, Bogos K and Tóvári J: Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Res 66: 7341-7347, 2009.
272. Sinkovics JG and Horvath JC: Human natural killer cells: a comprehensive review. Int J Oncol 27: 5-47, 2005.
273. Padykula HA and Taylor JM: Ultrastructural evidence for loss of the trophoblastic layer in the chorioallantoic placenta of Australian bandicoots (Marsupialia: Peramelidae). Anat Rec 186: 357-385, 1976.
274. Napertsikov VV and Dorosevich AE: Somatic cell hybridization as one of the mechanisms explaining the inadequacy of immunologic surveillance. Arkh Patol 49: 83-88, 1987.
275. Yunis EJ, Zuniga J, Romero V and Yunis EJ: Chimerism and tetragametic chimerism in humans: implications in autoimmunity, allorecognition and tolerance. Immunol Res 38: 213-236, 2007.
276. Larsson LI, Bjerregaard B and Talts JF: Cell fusions in mammals. Histochem Cell Biol 129: 551-561, 2008.
277. Haider S and Knöfler M: Human tumor necrosis factor: physiological and pathological roles in placenta and endometrium. Placenta 30: 11-123, 2009.
278. Xu CX, Hu ZM, Li JL and Gao JM: Expression, purification and refolding of streptovidin-tagged human necrosis factor-alpha fusion protein. Nan Fang Yi Ke Da Xue Xue Bao 29: 412-415, 2009.
279. Malassiné A, Handschuh K, Tsatsaris V, Gerbaud P, Cheynet V, Oriol G, Mallet F and Evain-Brion D: Expression of HERv-W Env glycoprotein (syncytin) in the extravillous trophoblast of first trimester human placenta. Placenta 26: 556-562, 2005.
280. Huppertz B and Borges M: Placenta trophoblast fusion. Methods Mol Biol 475: 135-147, 2008.
281. Dewlo S, Baczyk D, Dunk C and Kingdom J: Fusion assays and models for the trophoblast. Methods Mol Biol 475: 363-382, 1982.
282. Chen CP, Chen LF, Yang SR, Chen CY, Ko CC, Chang GD and Chen H: Functional characterization of the human placental fusogenic membrane protein syncytin 2. Biol Reprod 79: 815-823, 2008.
283. Noorali S, Rotar IC, Lewis C, Pestaner JP, Pace DG, Sison A and Bagasra O: Role of HERV-W syncytin-1 in placentation and maintenance of human pregnancy. Appl Immunohistochem Mol Morphol (In press).
284. Blond JL, Besme F, Duret L, Bouton O, Bedin F, Parron H, Mandrand B and Mallet F: Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J Virol 73: 1175-1185, 1999.
285. Tristem M: Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping database. J Virol 74: 3715-3730, 2000.
286. Frendo JL, Olivier D, Cheynet V, Blond JL, Bouton O, Vidaut M, Rabreau M, Evain-Brion D and Mallet F: Direct involvement of HERV-W Env glycoprotein in human trophoblast cell fusion and differentiation. Mol Cell Biol 23: 3566-3574, 2003.
287. Dolei A and Perron H: The multiple sclerosis-associated retrovirus and its HERV W endogenous family: a biological interface between virology, genetics, and immunology in human physiology and disease J Neurovirol 15: 4-13, 2008.
288. Drewlo S, Leyting S, Kokozidou M, Mallet F and Pötgens AJ: C-terminal truncations of syncytin-1 (ERVWE1 envelope) that increase its fusogenicity. Biol Chem 387: 1113-1120, 2006.
289. Malassiné A, Frendo JL, Blaise S, Handschuh K, Gerbeaud P, Tsatsaris V, Heidmann T and Evain-Brion D: Human endogenous retrovirus-FRD envelope protein (syncytin 2) expression in normal and trisomy 21-affected placenta. Retrovirology 5: 6, 2008.
290. Blaise S, de Parseval N, Bénit L and Heidmann T: Genomwide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved in primate evolution. Proc Natl Acad Sci USA 100: 13013-13018, 2003.
291. Blaise S, Ruggieri A, Dewannieux M, Cosset FL and Heidmann T: Identification of an envelope protein from the FRD family of human endogenous retroviruses (HERV-FRD) conferring infectivity and functional conservation among simians. J Virol 768: 1050-1054, 2004.
292. Esnault C, Priet S, Ribet D, Vernochet C, Bruis T, Lavialle C, Weissenbach J and Heidmann T: A placenta-specific receptor for the fusogenic, endogenous retrovirus-derived, human syncytin-2. Proc Natl Acad Sci USA 105: 17532-17537, 2008.
293. Mangeney M, Renard M, Schlecht-Louf G, Boullaga I, Heidmann O, Letzelter C, Richaud A, Ducos B and Heidmann T: Placental syncytins: Genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins. Proc Natl Acad Sci USA 104: 20534-20539, 2007.
294. Ruprecht K, Gronen F, Sauter M, Best B, Rieckmann P and Muellar-Lantzsch N: Lack of immune responses against multiple sclerosis-associated retrovirus/human endogenous retrovirus W in patients with multiple sclerosis. J Neurovirol 14: 143-151, 2008.
295. Wang-Johanning F, Radvanyi L, Rycaj K, Plummer JB, Yan P, Sastry KJ, Piyathilake CJ, Hunt KK and Johanning GL: Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients. Cancer Res 68: 5869-5877, 2008.
296. Rakoff-Nahoum S, Kuebler PJ, Heyman JJ, Sheehy MM, Ortiz GS, Ogg G, Barbour JD, Lenz J, Steinfeld AD and Nixon DF: Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma. AIDS Res Hum Retroviruses 22: 52-56, 2006.
297. Rote NS, Chakrabarty S and Stetzer BP: The role of human endogenous retroviruses in trophoblast differentiation and placental development. Placenta 25: 673-683, 2004.
298. Strick R, Ackdermann S, Langbein M, Swiatek J, Schubert SW, Hashemolhosseini S, Koschek T, Fasching PA, Schild RL, Beckmann MW and Strissel PL: Proliferation and cell-cell fusion of endometrial carcinoma are induced by the human endogenous retroviral syncytin-1 and regulated by TGF-beta. Mol Med 85: 23-38, 2007.
299. Bjerregaard B, Holck S, Christensen IJ and Larsson LI: Syncytin is involved in breast cancer-endothelial cell fusions. Cell Mol Life Sci 63: 1906-1911, 2006.
300. Zerangue N and Kavanaugh MP: ASCT-1 is a neutral amino acid exchanger with chloride channel activity. J Biol Chem 271: 27991-27994, 1996.
301. Li R, Younes M, Frolov A, Wheler TM, Scardino P, Ohori M and Ayala G: Expression of neutral amino acid transporter ASCT2 in human prostate. Anticancer Res 23: 3413-3418, 2003.
302. Kovacs G: Premature chromosome condensation: evidence for in vivo cell fusion in human malignant tumors. Int J Cancer 36: 637-641, 1985.
303. Wang X, Willenbring H, Akkari Y, Torimaru Y, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, Olson S and Grompe M: Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 422: 897-901, 2003.
304. Vassilopoulos G, Wang PR and Russell DW: Transplanted bone marrow regenerates liver by cell fusion. Nature 422: 901-904, 2003.
305. Camargo FD, Finegold M and Goodell MA: Hematopoietic myelomonocytic cells are the major source of hepatocyte fusion partners. J Clin Invest 113: 1266-1270, 2004.
306. Rizvi AZ, Swain JR, Davies PS, Bailey AS, Decker AD, Willenbring H, Grompe M, Fleming WH and Wong MH: Bone marrow-derived cells fuse with normal and transformed intestinal stem cells. Proc Natl Acad Sci USA 103: 6321-6325, 2006.
307. Hirayama E, Udaka Y, Kawai T and Kim J: Characterization of heterokaryons between skeletal myoblasts and somatic cells formed by fusion with HVJ (Sendai virus): effects on myogenic differentiation. Cell Struct Funct 26: 37-47, 2001.
308. Matsuura K, Wada N, Nagai T, Iijima Y, Minamino T, Sano M, Akazawa H, Molkentin JD, Kasanuki H and Komuro I: Cardiomyocytes fuse with surrounding noncardiomyocytes and reenter the cell cycle. J Cell Biol 167: 351-363, 2004.
309. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, Fike JR, Lee HO, Pfeffer K, Lois C, Morrison SJ and Alvarez-Buylla A: Fusion of non-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425: 968-973, 2003.
310. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II and Thomson JA: Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920, 2007.
311. Tweedell KS: New paths to pluripotent stem cells. Curr Stem Cell Res Ther 3: 151-162, 2008.
312. Janin A, Murata M, Leboeuf C, Cayuela JM, Gluckman E, Legrés L, Desveaux A, Varna M, Ratajczak P, Soulier J, De Thé H, Bertheau P and Socié G: Donor-derived oral squamous cell carcinoma after allogeneic bone marrow transplantation. Blood 113: 1834-1840, 2009.
313. Huu SN, Oster M, Avril M-F, Boitier F, Mortier L, Richard M-A, Kerob D, Maubec E, Souteyrand P, Moguelet P, Khosrotehrani K and Aractingi S: Fetal microchimeric cells participate in tumour angiogenesis in melanoma occurring during pregnancy. Am J Pathol 174: 630-637, 2009.
314. Xu Y, Darcy PK and Kershaw MH: Tumor-specific dendritic cells generated by genetic redirection of Toll-like receptor signaling against the tumor-associated antigen, erbB2. Cancer Gene Ther 14: 773-780, 2007.
315. Sinkovics JG: Viral oncolysates as human tumor vaccines. Int Rev Immunol 7: 259-287, 1991.
316. Sinkovics JG, Plager C, McMurtrey MJ, Romero JJ and Romsdahl MM: Immunotherapy of human sarcomas. In: Management of Primary Bone and Soft Tissue Tumors. Year Book Medical Publishers, Chicago, London, pp361-410, 1977.
317. Amaravadi RK and Thompson CR: The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin Cancer Res 13: 7271-7279, 2007.
318. Sinkovics JG: Cytolytic immune lymphocytes in the armamentarium of the human host. Acta Mirobiol Immunol Hung 55: 371-382, 2008. Errata: The author's title as submitted was 'Updating the monograph: Cytolytic Immune Lymphocytes...' etc etc. That title was editorialized without the permission of the publisher of the book of the same title, Schenk Verlag, and without notifying the author. The correct spellings are 'gnathostomata' and 'Benga'. The correct numbers of Figures in the monograph referred to in the article are '8ABCD; 8F1-10; 8G1-3; 8H1. [13, 24, 26]'. The correct wording of the sentence '... and CTLA4 (cytotoxic lymphocyte antigen), an inhibitor of T cell attack on 'self'. The correct wording of the sentence '...in the absence of pre-activated innate immunity in these recipients, induced more TREG and myeloid suppressor cells, ...'
319. Sinkovics JG, Hirano M, Szakacs A, Shullenberger CC and Howe CD: Growth of lymphoreticular malignant cells in the preconditioned murine host. In: The Proliferation and Spread of Neoplastic Cells. Williams & Wilkins, Baltimore, MD, pp615-639, 1968.
320. Dudley ME and Rosenberg SA: Adoptive cell transfer therapy. Semin Oncol 34: 524-531, 2007.
321. Miyagawa Y, Okita H, Itagaki M, Toyoda M, Katagiri YU, Fujimoto J, Hata J, Umezawa A and Kijokawa N: EWS/ETS regulates the expression of the dickkopf family in Ewing family tumor cells. PLoS ONE 4: e4634, 2009.
322. Tang S, Guo W, Guo Y, Qu HY and Li DS: In vitro antitumor immune response induced by fusion of dendritic cells and Ewing's sarcoma cells. Zhonghua Wai Ke Za Zhi 43: 803-806, 2005.
323. Zhao H, Tang S, Qu HY, Guo W, Li X and Peng CL: Comparison and analysis of different dendritic cell-based immunotherapeutic strategies for Ewing sarcoma: in vitro and in vivo induction on SCID mouse models. Beijing Da Xue Xue Bao 39: 403-408, 2007.
324. Guo W, Guo Y, Tang S, Qu H and Zhao H: Dendritic cell-Ewing's sarcoma cell hybrids enhance antitumor immunity. Clin Orthop Relat Res 466: 2176-2183, 2008.
325. Palma M, Adamson L, Hansson L, Kokhaei P, Rezvany R, Mellstedt H, Ostenborg A and Choudhury A: Development of a dendritic cell-based vaccine for chronic lymphocytic leukemia. Cancer Immunol Immunother 57: 1705-1710, 2008.
326. Levenga H, Woestenenk R, Schattenberg AV, Maas F, Jansen JH, Raymakers R, De Mulder PH, van de Wiel-van Kemenade E, Schaap N, De Witte T and Dolstra H: Dynamics in chimerism of T cells and dendritic cells in relapsed CML patients and the influence on the induction of alloreactivity following donor lymphocyte infusion. Bone Marrow Transplant 40: 585-592, 2007.
327. Redman BG, Chang AE, Whitfield J, Esper P, Jiang G, Braun T, Roessler B and Mulé JJ: Phase I trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma. J Immunother 31: 591-598, 2008.
328. López MN, Pereda C, Segal G, Muñoz L, Aguilera R, González FE, Escobar A, Ginesta A, Reyes D, Gonz-acalez R, Mendoza-Naranjo A, Larrondo M, Compán C and Salazar-Onfray F: Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor β-expressing T cells. J Clin Oncol 27: 945-952, 2009.
329. Trefzer U, Herberth G, Wohlan K, Milling A, Thiemabnn M, Sharov T, Sparbier K, Sterry W and Walden P: Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical results. Vaccine 23: 2367-2373, 2005.
330. Engell-Noerreggaard L, Hansen TH, Andersen MH, Thor Straten P and Svane IM: Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters. Cancer Immunol Immunother 58: 1-14, 2009.
331. Vasir B, Borgwes V, Wu Z, Grosman D, Rosenblatt J, Irie M, Andserson K, Kufe D and Avigan DL: Fusion of dendritic cells with multiple myeloma cells results in maturation and enhanced antigen presentation. Br J Haematol 129: 687-700, 2005.
332. Ch'ng S and Tan ST: Genetics, cellular biology and tumor microenvironment of melanoma. Front Biosci 14: 918-928 2009.
333. Koido S, Tanaka Y, Tajiri H and Gong J: Generation and functional assessment of antigen-specific T cells stimulated by fusions of dendritic cells and allogeneic breast cancer cells. Vaccine 25: 2610-2619, 2007.
334. Serhal K, Baillou C, Ghinea N, Fontanges P, Dupuy FP, Lemoine FM and Lacave R: Characteristics of hybrid cells obtained by dendritic cell/ tumor cell fusion in a T47D breast cancer cell line model indicate their potential as anti-tumor vaccines. Int J Oncol 31: 1357-1365, 2007.
335. Koido S, Nikrui N, Ohana M, Xia J, Tanaka Y, Liu C, Durfee JK, Lerner A and Gong J: Assessment of fusion cells from patient-derived ovarian carcinoma cells and dendritic cells as vaccines for clinical use. Gynecol Oncol 99: 462-471, 2005.
336. Guan X, Peng JR and Leng XS: Establishment of dendritomas by fusion of human dendritic cells with human hepatocellular carcinoma cell line HLE cells. Zhonghua Zhong Liu Za Zhi 27: 465-467, 2005.
337. Avigan DE, Vasir B, George DJ, Oh WK, Atkins MB, McDermott DF, Kantoff PW, Figlin RA, Vasconcelles MJ, Xu Y, Kufe D and Bukowski RM: Phase I/II study of vaccination with electrofused allogeneic dendritic cell/ autologous tumor-derived cells in patients with stage IV renal cell carcinoma. J Immunother 30: 749-761, 2007.
338. Zhou J, Werng D, Zhou F, Pan K, Song H, Wang Q, Wang H, Wang H, Li Y, Huang L, Zhang H, Huang W and Xia J: Patient-derived renal cell carcinoma cells fused with allogeneic dendritic cells elicit anti-tumor activity: in vitro results and clinical responses. Cancer Immunol Immunother (In press).
339. Shu S, Zheng R, Lee WT and Cohen PA: Immunogenicity of dendritic-tumor fusion hybrids and their utility in cancer immunotherapy. Crit Rev Immunol 27 463-483, 2007.
340. Worschech A, Kmieciak M, Knutson KL, Bear HD, Szalay AA, Wang E, Marincola FM and Manjili MH: Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors. Cancer Res 68: 2436-2446, 2008.
341. Mahic M, Henjum K, Yaqub S, Bj-dsornbeth BA, Torgersen KM, Taskén K and Aandahl EM: Generation of highly suppressive adaptive CD8(+)CD25(+) FOXP3(+) regulatory T cells by continuous antigen stimulation. Eur J Immunol 38: 640-646, 2008.
342. Bilik R, Mor C, Hazaz B and Moroz C: Characterization of T-lymphocyte subpopulations infiltrating primary breast cancer. Cancer Immunol Immunother 28: 143-147, 1989.
343. Santisteban M, Reiman JM, Asiedu MK, Behrens MD, Nassar A, Kalli KR, Haluska P, Ingle JN, Hartmann LC, Manjili MH, Radisky DC, Ferrone S and Knutson KL: Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Res 69: 2887-2895, 2009.
344. Waerner T, Alacakaptan M, Tamir I, Oberauer R, Gal A, Brabletz T, Schreiber M, Jechlinger M and Beug H: ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells. Cancer Cell 10: 227-239, 2006.
345. Lahsnig C, Mikula M, Petz M, Zulehner G, Schneller D, van Zijl F, Huber H, Csisaar A, Beug H and Mikulits W: ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression. Oncogene 28: 638-650, 2009.
346. Guo J, Cheng H, Zhao S and Yu L: mGG: a domain involved in phage LFT apparatus and implicated in human MEB and non-syndrome hearing loss diseases. FEBS Lett 580: 581-584, 2006.
347. Pilipenko VV, Reece A, Choo DI and Greinwald JH Jr: Genomic organization and expression analysis of the murine Fam3c gene. Gene 335: 159-168, 2004.
348. Gr-osnborg M, Kristiansen TZ, Iwahori A, Chang R, Reddy R, Sato N, Molina H, Jensen ON, Hruban RH, Goggins MG, Maitra A and Pandey A: Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics 5: 157-171, 2006.
349. Manjili MH, Arnouik H, Knutson KL, Mieciak M, Disis ML, Subjeck JR and Kazim AL: Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce 'danger signals'. Breast Cancer Res Treat 96: 233-241, 2006.
350. Morel A-P, Li-grevre M, Thomas C, Hinkal G, Ansieau S and Puisieux A: Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 3: e2888, pp1-11, 2008.
351. Zhu Y, Xu G, Patel A, McLaughlin MM, Silverman C, Knecht K, Sweitzer S, Li X, McDonnell P, Mirabile R, Zimmerman D, Boyce R, Tierney LA, Hu E, Livi GP, Wolf B, Abdel-Meguid SS, Rose GD, Aurora R, Hensley P, Briggs M and Young PR: Cloning, expression, and initial characterization of a novel cytokine-like gene family. Genomics 80: 144-150, 2002.
352. Cao X. Gao Z, Robert C, Greene, Xu G, Xu W, Bell W, Campbell D, Zhu Y, Young R, Trucco M, Markmann JF, Naji A and Wolf BA: Pancreatic-derived factor (FAM3B), a novel islet cytoline, induces apoptosis of insulin-secreting β-cells. Diabetes 52: 2296-2303, 2003.
353. Xu W, Gao Z, Wu J and Wolf BA: Interferon-gamma-induced regulation of the pancreatic-derived cytokine FAM3B in islets and insulin-secreting betaTC3 cells. Mol Cell Endocrinol 240: 74-81, 2005.
354. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J and Weinberg RA: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715, 2008.
355. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988, 2003.
356. Dick JE: Breast cancer stem cells revealed. Proc Natl Acad Sci USA 100: 3547-3549, 2003.
357. González-Sarmiento R and Pérez-Losada J: Breast cancer, a stem cell disease. Curr Stem Cell Res Ther 3: 55-65, 2008.
358. Marcato P, Dean CA, Giacomantonio CA and Lee PW: Oncolytic reovirus effectively targets breast cancer stem cells. Mol Ther 17: 972-979, 2009.
359. Coffey MC, Strong JE, Forsyth PA and Lee PW: Reovirus therapy of tumors with activated Ras pathway. Science 282: 1332-1334, 1998.
360. Thirukkumaran CM, Luider JM, Stewart DA, Cheng T, Lupichuk SM, Nodwell MJ, Russell JA, Auer IA and Morris DG: Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation. Blood 102: 377-387, 2003.
361. Thirukkumaran CM, Luider JM, Stewart DA, Alain T, Russell JA, Auer IA, Forsyth P and Morris DG: Biological purging of breast cancer cell lines using a replication-competent oncolytic virus in human stemcell autografts. Bone Marrow Transplant 35: 1055-1064, 2005.
362. Gao Y, Whitaker-Dowling P, Griffin JA, Barmada MA and Bergman I: Recombinant vesiclular stomatitis virus targeted to Her2/neu combined with anti-CTLA4 antibody eliminates implanted mammary tumors. Cancer Gene Ther 16: 44-52, 2009.
363. Sinkovics JG, Bertin B and Howe CD: Some properties of the photodynamically inactivated Rauscher mouse leukemia virus. Cancer Res 25: 624-627, 1965.
364. Sinkovics JG, Pienta RJ, Trujillo JM and Ahearn MJ: An immunological explanation for the starry sky histological pattern of a malignant lymphoma. J Infect Dis 120: 250-254, 1969.
365. Trujillo JM, Ahearn MJ, Pienta RJ, Gott C and Sinkovics JG: Immunocompetence of leukemic murine lymphoblasts: ultrastructure, virus and globulin production. Cancer Res 30: 540-545, 1970.